Key facts
- Status: Privately Held (backing).
- ·Watchlist + deal alerts for Steps Bio
- ·The full record, as it builds
Funding rounds
No funding rounds for Steps Bio are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Steps Bio
Developer of cell therapy manufacturing technology designed for scalable production of engineered immune cells for therapeutic use. The company's platform integrates automated cell processing workflows, closed-system manufacturing units, culture optimization protocols, quality control analytics, and data tracking capabilities across development and production stages, enabling biotechnology and pharmaceutical companies to standardize cell therapy manufacturing, improve reproducibility, and support clinical and commercial-scale therapeutic development.
- Sector
- Healthcare
- HQ
- Scotch Plains, NJ, United States
- Founded
- 2018
- Website
- stepsbio.com/
- Ownership
- Privately Held (backing)
Steps Bio doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Steps Bio shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Steps Bio in its N-PORT filings yet. We sweep new filings monthly.